论文部分内容阅读
为进一步探索铝碳酸镁的临床应用价值，用其片剂和雷尼替丁对７０例消化性溃疡（ＰＵ）的临床疗效进行了对比观察，结果治疗前后试验组（Ａ组）疼痛完全消失者３０例（８５．７％），对照组（Ｂ组）２９例（８２．９％），Ａ，Ｂ两组疼痛缓解率差异无显著性（Ｐ＞０．０５）。溃疡愈合情况Ａ组胃溃疡（ＧＵ）病人有效８例（８０％），Ｂ组有效７例（７０％），两组比较差异无显著性（Ｐ＞０．０５）．结果表明铝碳酸镁与雷尼替丁治疗ＧＵ差异无显著性。十二指肠溃疡（ＤＵ）病人Ａ组有效２２例（８８％），Ｂ组有效２１例（８４％），两组比较差异无显著性（Ｐ＞０．０５），表明铝碳酸镁与雷尼替丁治疗ＰＵ效果相似。Ａ组总有效３０例（８５．７％），３组，总有效２８例（８０％）（Ｐ＞０．０５），提示可将铝碳酸镁作为雷尼替丁治疗ＰＵ的代用品。
To further explore the clinical value of magnesium aluminum carbonate, the tablets and ranitidine 70 cases of peptic ulcer (PU) were compared the clinical efficacy of the results before and after treatment in the experimental group (A group) pain disappeared Thirty patients (85.7%) and control group (B), 29 patients (82.9%). There was no significant difference in pain relief rate between A and B groups (P> 0.05). In the group of ulcer (GU), 8 cases (80%) were effective in group A and 7 cases (70%) in group B, there was no significant difference between the two groups (P> 0.05). The results showed that magnesium aluminum and ranitidine GU treatment was no significant difference. In duodenal ulcer (DU) patients, 22 cases (88%) were effective in group A and 21 cases (84%) in group B, there was no significant difference between the two groups (P> 0.05) Nitidine treatment of PU effect is similar. A group of 30 cases (85.7%), three groups, the total effective 28 cases (80%) (P> 0.05), suggesting that aluminum magnesium carbonate can be ranitidine treatment of PU substitutes.